Research ArticlePediatric Rheumatology
Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab
Shumpei Yokota, Yasuhiko Itoh, Tomohiro Morio, Naokata Sumitomo, Kaori Daimaru and Seiji Minota
The Journal of Rheumatology April 2015, 42 (4) 712-722; DOI: https://doi.org/10.3899/jrheum.140288
Shumpei Yokota
From The Safety Evaluation Committee of Tocilizumab for JIA; Department of Pediatrics, Nippon Medical School; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU) Graduate School of Medical and Dental Sciences; Chugai Pharmaceutical Co. Ltd., Tokyo; Department of Pediatrics, Yokohama City University School of Medicine, Kanagawa; Department of Pediatric Cardiology, Saitama Medical University International Medical Center, Saitama; Division of Rheumatology and Clinical Immunology, Jichi Medical School, Tochigi,
Japan.
Yasuhiko Itoh
Tomohiro Morio
Naokata Sumitomo
Kaori Daimaru
REFERENCES
- 1.↵
- Cassidy JT,
- Petty RE,
- Laxer R,
- Lindsley C
- Cassidy JT,
- Petty RE
- 2.↵
- 3.↵
- 4.↵
- 5.↵
- Sawhney S,
- Woo P,
- Murray KJ
- 6.↵
- 7.↵
- 8.↵
- 9.↵
- 10.↵Pharmaceuticals and Medical Devices Agency, Japan. [Actemra for intravenous infusion. Japanese product information, Tokyo]. [Article in Japanese; Internet. Accessed January 9, 2015.] Available from: chugai-pharm.jp/hc/ss/pr/drug/act_via0080/pi/index.html
- 11.↵
- 12.↵
- US Food Drug Administration
- 13.↵
- European Medicines Agency
- 14.↵
- Behrens EM,
- Beukelman T,
- Paessler M,
- Cron RQ
- 15.↵
- Davì S,
- Consolaro A,
- Guseinova D,
- Pistorio A,
- Ruperto N,
- Martini A,
- et al.
- 16.↵
- 17.↵
- Bradham CA,
- Qian T,
- Streetz K,
- Trautwein C,
- Brenner DA,
- Lemasters JJ
- 18.↵
- 19.↵
- 20.↵
- Castillo L,
- Carcillo J
- 21.↵
- 22.↵
- 23.↵
- Nakajima S,
- Naruto T,
- Miyamae T,
- Imagawa T,
- Mori M,
- Nishimaki S,
- et al.
- 24.↵
- 25.↵
- 26.↵
- 27.↵
- Sawar H,
- Espinoza LR,
- Gedalia A
- 28.↵
- 29.↵
- 30.↵
- 31.↵
- Yanagimachi M,
- Naruto T,
- Miyamae T,
- Hara T,
- Kikuchi M,
- Hara R,
- et al.
- 32.↵
- Stéphan JL,
- Koné-Paut I,
- Galambrun C,
- Mouy R,
- Bader-Meunier B,
- Prieur AM
- 33.↵
- 34.↵
- Demirkol D,
- Yildizdas D,
- Bayrakci B,
- Karapinar B,
- Kendirli T,
- Koroglu TF,
- et al.
- 35.↵
- 36.↵
- 37.↵
- 38.↵
- 39.↵
- 40.↵
- Jordan MB,
- Hildeman D,
- Kappler J,
- Marrack P
- 41.↵
- Milner JD,
- Orekov T,
- Ward JM,
- Cheng L,
- Torres-Velez F,
- Junttila I,
- et al.
- 42.↵
- Zoller EE,
- Lykens JE,
- Terrell CE,
- Aliberti J,
- Filipovich AH,
- Henson PM,
- et al.
- 43.↵
- 44.↵
- 45.↵
- Wulffraat NM,
- Rijkers GT,
- Elst E,
- Brooimans R,
- Kuis W
In this issue
The Journal of Rheumatology
Vol. 42, Issue 4
1 Apr 2015
Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab
Shumpei Yokota, Yasuhiko Itoh, Tomohiro Morio, Naokata Sumitomo, Kaori Daimaru, Seiji Minota
The Journal of Rheumatology Apr 2015, 42 (4) 712-722; DOI: 10.3899/jrheum.140288